Left Atrial Appendage Occlusion in Patients With Non-valvular Atrial Fibrillation From Shanghai
LAAO-SH
Prognostic Implications of Left Atrial Appendage Occlusion in Patients With Non-valvular Atrial Fibrillation at Shanghai Tenth People's Hospital
1 other identifier
observational
150
1 country
1
Brief Summary
The prognostic implication of left atrial appendage occlusion (LAAO) procedure in non-valvular atrial fibrillation (NVAF) patients from China is still unclear. We aim to investigate the impact of LAAO procedure on subsequent clinical outcomes in patients from China.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2019
CompletedFirst Submitted
Initial submission to the registry
June 14, 2019
CompletedFirst Posted
Study publicly available on registry
June 17, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2020
CompletedJune 17, 2019
June 1, 2019
8 months
June 14, 2019
June 14, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Major adverse cardiovascular and cerebral events (MACCE)
A composite of all-cause death, ischemic stroke, heart failure rehospitalization and major bleeding events
From the time of performing LAAO procedure until occurrence of an outcome of interest, death, lose to follow up or Jan, 2020, maximum up to 6 years
Secondary Outcomes (6)
All-cause death
From the time of performing LAAO procedure until occurrence of death, lose to follow up or Jan, 2020, maximum up to 6 years
Cardiovascular death
From the time of performing LAAO procedure until occurrence of death, lose to follow up or Jan, 2020, maximum up to 6 years
Ischemic stroke
From the time of performing LAAO procedure until occurrence of an outcome of interest, death, lose to follow up or Jan, 2020, maximum up to 6 years
Major bleeding
From the time of performing LAAO procedure until occurrence of an outcome of interest, death, lose to follow up or Jan, 2020, maximum up to 6 years
Heart failure rehospitalization
From the time of performing LAAO procedure until occurrence of an outcome of interest, death, lose to follow up or Jan, 2020, maximum up to 6 years
- +1 more secondary outcomes
Study Arms (1)
Left atrial appendage occlusion
Patients with non-valvular atrial fibrillation who have received left atrial appendage occlusion procedure.
Interventions
All NVAF patients who are admitted for receiving left atrial appendage occlusion procedure, including Watchman, LAmbre, Lefort, and Leftear deveices.
Eligibility Criteria
All patients with NVAF who are referred for LAAO procedure.
You may qualify if:
- Patients who were admitted for NVAF undergoing LAAO procedure between January 2014 and December 2017 in the Cardiology Department of Shanghai Tenth People's Hospital;
- Adult patients (\>18 years old).
You may not qualify if:
- Patients with rheumatic valvular disease;
- Patients with sick sinus syndrome;
- Patients who had a history of cardiac surgery (i.e., CABG);
- patients who had received the catheter radiofrequency ablation procedure.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Cardiology, Shanghai Tenth People's Hospital
Shanghai, Shanghai Municipality, 200072, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yawei Xu, M.D., Ph.D.
Department of Cardiology, Shanghai Tenth People's Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief Physician
Study Record Dates
First Submitted
June 14, 2019
First Posted
June 17, 2019
Study Start
May 1, 2019
Primary Completion
December 31, 2019
Study Completion
June 30, 2020
Last Updated
June 17, 2019
Record last verified: 2019-06